Free Trial

EMA Presser On J&J Vaccine 1700CET

EUROPE

The European Medicines Agency tweets: "A press briefing on EMA's safety committee (PRAC) review of #COVID19Vaccine Janssen and blood clots is planned at 5:00 PM CET [1100ET, 1600BST] today. Follow live on YouTube: https://t.co/H4xlcn1Cok"

  • The shipping of the Janssen/J&J vaccine from the US to the EU has been postponed while the US pauses the rollout of the one-shot vaccine amidst a review of side effects.
  • EU has already stated it will not buy more J&J vaccines beyond its initial order of 200mn doses, instead focusing on mRNA vaccines from Pfizer/BioNTech and Moderna. Under the contract with J&J the EU had the option of ordering 200mn additional doses.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.